Clinical trial NL-OMON49322
Status: Recruiting (according to the registry)Phase not statedLatest change: Source: OMON (Netherlands) (via WHO ICTRP)
What's on this page?
This record’s status may be out of date
The trial was registered in October 22, 2020 and still shows as "recruiting" in the registry. Status information in other countries’ registries is often not updated; the trial may have ended or stopped. For current information, check the record itself.
Information in the record
Original title: A phase 2a study on the anti-tumoral effect of cannabis oil (THC 10% / CBD 5%) in patients with untreatable advanced hepatocellular carcinoma
- Record number
- NL-OMON49322
- Registry
- OMON (Netherlands) (via WHO ICTRP)
- Status
- Recruiting (according to the registry)
- Type and phase
- Clinical trial, phase not stated
- Participants
- Target: 20
- Condition (as registered)
- hepatocellular carcinoma (liver cancer), 10019815
- Countries
- Netherlands
- Topic in the guide
- Cancer Treatment
Timeline
According to the OMON (Netherlands) (via WHO ICTRP) record. Future dates are the investigator’s estimates and may change.
- Registration: October 22, 2020
History
We check the record once a month via WHO ICTRP; here are the changes we have seen since we started tracking it, newest first.
- : Added to tracking. Status: Recruiting.
Results
No results have been published yet. When they are, they will appear here. A trial being under way does not mean CBD works for this condition; only the results can show that.
All ongoing trials · Cancer Treatment: guide page · Thinking of taking part? Which specialist to see